Research Interests
Our team focuses on advanced biopharmaceuticals, with particular expertise in the development and application of extracellular vesicles (EVs) and lipid nanoparticles (LNPs). We actively explore innovative delivery strategies for a wide range of therapeutic agents, including genetic materials, lipo-peptides, proteins, and small molecules.
Beyond laboratory research, we are strongly committed to academic–industry collaboration, bridging scientific innovation with real-world applications. Our group is affiliated with the CHA Advanced Research Institute, Extracellular Vesicle (EV) Center, where we contribute to advancing EV-based therapeutic platforms.
We maintain active collaborations with leading biopharmaceutical companies such as CMG Pharmaceuticals, CHA Vaccine Research Institute, CHA Biotech, and Matica BioLabs. These partnerships not only accelerate translational research but also create valuable opportunities for students and young scientists to connect with industry leaders. Such close academia–industry engagement is a key strength of our team, supporting both scientific progress and career development for the next generation.